Optimized dosing of guideline-directed medical therapies is essential in heart failure with reduced ejection fraction

被引:0
作者
Faaborg-Andersen, Christian C. [1 ,4 ]
daSilva-deAbreu, Adrian [2 ]
Ventura, Hector O. [3 ]
机构
[1] Massachusetts Gen Hosp, Dept Internal Med, Boston, MA 02114 USA
[2] Mayo Clin, Dept Cardiovasc Med, Rochester, MN USA
[3] Ochsner Med Ctr, John Ochsner Heart & Vasc Inst, New Orleans, LA USA
[4] Massachusetts Gen Hosp, 55 Fruit St, Boston, MA 02114 USA
关键词
D O I
10.1016/j.ijcard.2022.10.137
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:325 / 326
页数:2
相关论文
共 12 条
  • [1] Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial A Secondary Analysis of a Randomized Clinical Trial
    Fiuzat, Mona
    Ezekowitz, Justin
    Alemayehu, Wendimagegn
    Westerhout, Cynthia M.
    Sbolli, Marco
    Cani, Dario
    Whellan, David J.
    Ahmad, Tariq
    Adams, Kirkwood
    Pina, Ileana L.
    Patel, Chetan B.
    Anstrom, Kevin J.
    Cooper, Lawton S.
    Mark, Daniel
    Leifer, Eric S.
    Felker, G. Michael
    Januzzi, James L.
    O'Connor, Christopher M.
    [J]. JAMA CARDIOLOGY, 2020, 5 (07) : 757 - 764
  • [2] Medical Therapy for Heart Failure With Reduced Ejection Fraction
    Greene, Stephen J.
    Butler, Javed
    Albert, Nancy M.
    DeVore, Adam D.
    Sharma, Puza P.
    Duffy, Carol I.
    Hill, C. Larry
    McCague, Kevin
    Mi, Xiaojuan
    Patterson, J. Herbert
    Spertus, John A.
    Thomas, Laine
    Williams, Fredonia B.
    Hernandez, Adrian F.
    Fonarow, Gregg C.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (04) : 351 - 366
  • [3] 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
    Heidenreich, Paul A.
    Bozkurt, Biykem
    Aguilar, David
    Allen, Larry A.
    Byun, Joni J.
    Colvin, Monica M.
    Deswal, Anita
    Drazner, Mark H.
    Dunlay, Shannon M.
    Evers, Linda R.
    Fang, James C.
    Fedson, Savitri E.
    Fonarow, Gregg C.
    Hayek, Salim S.
    Hernandez, Adrian F.
    Khazanie, Prateeti
    Kittleson, Michelle M.
    Lee, Christopher S.
    Link, Mark S.
    Milano, Carmelo A.
    Nnacheta, Lorraine C.
    Sandhu, Alexander T.
    Stevenson, Lynne Warner
    Vardeny, Orly
    Vest, Amanda R.
    Yancy, Clyde W.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (17) : E253 - E421
  • [4] Jarjour M., 2022, INT J CARDIOL
  • [5] Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial
    Konstam, Marvin A.
    Neaton, James D.
    Dickstein, Kenneth
    Drexler, Helmut
    Komajda, Michel
    Martinez, Felipe A.
    Riegger, Gunter A. J.
    Malbecq, William
    Smith, Ronald D.
    Guptha, Soneil
    Poole-Wilson, Philip A.
    [J]. LANCET, 2009, 374 (9704) : 1840 - 1848
  • [6] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
    McMurray, J. J. V.
    Solomon, S. D.
    Inzucchi, S. E.
    Kober, L.
    Kosiborod, M. N.
    Martinez, F. A.
    Ponikowski, P.
    Sabatine, M. S.
    Anand, I. S.
    Belohlavek, J.
    Bohm, M.
    Chiang, C. -E.
    Chopra, V. K.
    de Boer, R. A.
    Desai, A. S.
    Diez, M.
    Drozdz, J.
    Dukat, A.
    Ge, J.
    Howlett, J. G.
    Katova, T.
    Kitakaze, M.
    Ljungman, C. E. A.
    Merkely, B.
    Nicolau, J. C.
    O'Meara, E.
    Petrie, M. C.
    Vinh, P. N.
    Schou, M.
    Tereshchenko, S.
    Verma, S.
    Held, C.
    DeMets, D. L.
    Docherty, K. F.
    Jhund, P. S.
    Bengtsson, O.
    Sjostrand, M.
    Langkilde, A. -M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21) : 1995 - 2008
  • [7] Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure
    Packer, M
    Poole-Wilson, PA
    Armstrong, PW
    Cleland, JGF
    Horowitz, JD
    Massie, BM
    Rydén, L
    Thygesen, K
    Uretsky, BF
    [J]. CIRCULATION, 1999, 100 (23) : 2312 - 2318
  • [8] Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
    Packer, Milton
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Pocock, Stuart J.
    Carson, Peter
    Januzzi, James
    Verma, Subodh
    Tsutsui, Hiroyuki
    Brueckmann, Martina
    Jamal, Waheed
    Kimura, Karen
    Schnee, Janet
    Zeller, Cordula
    Cotton, Daniel
    Bocchi, Edimar
    Boehm, Michael
    Choi, Dong-Ju
    Chopra, Vijay
    Chuquiure, Eduardo
    Giannetti, Nadia
    Janssens, Stefan
    Zhang, Jian
    Juanatey, Jose R. Gonzalez
    Kaul, Sanjay
    Brunner-La Rocca, Hans-Peter
    Merkely, Bela
    Nicholls, Stephen J.
    Perrone, Sergio
    Pina, Ileana
    Ponikowski, Piotr
    Sattar, Naveed
    Senni, Michele
    Seronde, Marie-France
    Spinar, Jindrich
    Squire, Iain
    Taddei, Stefano
    Wanner, Christoph
    Zannad, Faiez
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (15) : 1413 - 1424
  • [9] Titration of medical therapy and clinical outcomes among patients with heart failure with reduced ejection fraction: Findings from the HF-ACTION trial
    Pierce, Jacob B.
    Mentz, Robert J.
    Sun, Jie-Lena
    Alhanti, Brooke
    Whellan, David J.
    Kraus, William E.
    Pina, Ileana L.
    Fiuzat, Mona
    O'Connor, Christopher M.
    Greene, Stephen J.
    [J]. AMERICAN HEART JOURNAL, 2022, 251 : 115 - 126
  • [10] Epidemiology of Heart Failure A Contemporary Perspective
    Roger, Veronique L.
    [J]. CIRCULATION RESEARCH, 2021, 128 (10) : 1421 - 1434